Trade AbbVie ABBV

Sell
 Buy

AbbVie live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

AbbVie News

Frances Wang 2025 Nov 09, 16:00

Growth tech stocks to watch 2026: Nvidia (NVDA) stock, Netflix (NFLX)

Frances Wang 2025 Nov 09, 16:00

Crypto trading basics: What is Ethereum? Does ETH have any future?

Frances Wang 2025 Nov 09, 16:00

A guide to crypto ETFs: Bitcoin ETF vs. Ethereum ETF, what’s the difference?

Ava Grace 2025 Nov 08, 00:00

AI Funding Concerns Trigger Tech Stock Sell-Off

Sophia Claire 2025 Nov 08, 00:00

Gold Price Outlook: Currency Devaluation Trade Still Alive

Liam James 2025 Nov 08, 00:00

JPMorgan Sees Buying Opportunity Amid Market Jitters

Emma Rose 2025 Nov 07, 00:00

The Fed's Balance Sheet Expansion: Drivers and Potential Implications

Frances Wang 2025 Nov 06, 16:00

Gold and silver prices are up: what's happening to Gold (XAU/USD) and XAG?

Frances Wang 2025 Nov 06, 16:00

Nvidia Competitors Analysis (2026), NVDA Stock: AMD, Intel, Qualcomm, AVGO

Frances Wang 2025 Nov 05, 16:00

Crypto market update: Ethereum price drops, Bitcoin price falls below $104K

Latest news

Show more
Ava Grace 2025 Nov 10, 08:10

Huma Finance Appoints Jessica Cao as APAC CEO to Accelerate Growth

Ava Grace 2025 Nov 10, 08:10

How We Made +$50M Sniping Shitcoins on DEXs: A Financial Perspective

Liam James 2025 Nov 10, 07:20

The Future of Stablecoin FX: A Look at Numo, Mento, and ViFi

Ava Grace 2025 Nov 10, 07:10

DeFi Protocol Losses: Risk Management Lessons and Mitigation Strategies

Sophia Claire 2025 Nov 10, 06:50

Daily Market Review & Trend Analysis: November 10th

Liam James 2025 Nov 10, 06:10

Long-Term Bitcoin Holders: Strategic Shifts to ETFs and Portfolio Diversification

Noah Lee 2025 Nov 10, 06:10

BlackRock's Tokenization Revolution: A Decentralization Illusion?

Noah Lee 2025 Nov 10, 04:40

Bitcoin Treasury Firms: Is the Downturn Nearing its End?

Info

Spread

1.45

Spread (%)

0.6645 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

14:31 - 20:59

Tuesday

14:31-20:59

Wednesday

14:31-20:59

Thursday

14:31-20:59

Friday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

387340009472

Shares Outstanding

1767384632

Earnings Date (Next)

0000-00-00

Div Yield

2026-02-17

Ex-Dividend Date

2026-01-16

Forward annual dividend rate

6.92

Forward annual dividend yield

0.0316

EPS

1.31

Learn more about this instrument

AbbVie AbbVie Inc
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, generalized pustular psoriasis, and pyoderma gangrenosum; Skyrizi to treat autoimmune diseases, erythrodermic psoriasis, generalized pustular psoriasis, and palmoplantar pustulosis; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta/Venclyxto to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic to treat neurologic diseases; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duopa and Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; and Qulipta for episodic and chronic migraine, as well as other neuroscience products. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Ghko B 2025 Nov 06, 16:00

How to start cryptocurrency trading: how to trade BTC Price (BTC/USD) CFDs?

Ghko B 2025 Nov 06, 16:00

Xom Stock Forecast: What is the future forecast for XOM?

Ghko B 2025 Nov 06, 16:00

Top Australian Shares: Argo Investments, BHP, CBA stock and more

Trustpilot